Physician profile
Ali Seifi
NPI 1295960953
$57,547.92
in general payments reported to CMS, 2019-2025
7 companies · $6,528 in 2025
The $6,528 reported for 2025 was more than what 95% of Neurocritical Care providers received nationally (typical 2025 total: $95.82).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,117 · 2020: $5,849 · 2021: $12K · 2022: $12K · 2023: $7,210 · 2024: $5,937 · 2025: $6,528.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $18K · Honoraria: $910 · Food and Beverage: $786 · Travel and Lodging: $58.96.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $17,920.00 |
| Honoraria | $910.00 |
| Food and Beverage | $785.77 |
| Travel and Lodging | $58.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Chiesi USA, INC. | $56,167.56 | 2019-2025 | Cleviprex |
| Ceribell, INC. | $1,000.00 | 2019 | |
| Ucb, INC. | $159.60 | 2024 | Briviact |
| Sanofi US Services INC. | $150.34 | 2019 | |
| Corium, LLC | $31.46 | 2023 | Adlarity |
| Integra Lifesciences Corporation | $23.04 | 2022 | |
| Irras USA, INC. | $15.92 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ali Seifi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.